Intelligence · Clinical Pipeline
Tour Hekla Pipeline
All ClinicalTrials.gov programs at Tour Hekla — phase, modality, and trial IDs.
- Programs
- 10
Quick answer
Tour Hekla has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
ACTILYSE, poudre et solvant pour solution injectable et perfusion, ACTILYSE, poudre et solvant pour solution injectable et perfusion, Metalyse 10,000 units powder and solvent for solution for injection, ACTILYSE, poudre et solvant pour solution injectable et perfusion, Metalyse 5 000 units (25 mg) powder for solution for injection
Tour Hekla
Acute ischaemic stroke due to basilar artery occlusion.
1 trial -
AMIKACINE VIATRIS 1 g, poudre pour solution injectable en flacon, CHLORURE DE SODIUM 0,9 % COOPER, solution pour perfusion
Tour Hekla
Patients with ventilator-associated tracheobronchitis
1 trial -
ASPRO 320 mg, comprimé, CALCIUM HYDROGEN PHOSPHATE DIHYDRATE, DICLOFENAC ARROW 1 %, gel en flacon pressurisé
Tour Hekla
Thrombotic episodes in superficial venous malformations in children
1 trial -
Dexmedetomidine 100 micrograms/ml concentrate for solution for infusion, Midazolam Lek 1 mg/ml raztopina za injiciranje/infundiranje
Tour Hekla
Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care:
1 trial -
FOSFOMYCIN , SULFAMETHOXAZOLE AND TRIMETHOPRIM
Tour Hekla
Benign Prostate Hyperplasia
1 trial -
Medical Air, KALINOX 50%/50%, gaz médicinal comprimé
Tour Hekla
Resistant Depression in the Elderly Subject
1 trial -
OXYGENE MEDICINAL LIQUIDE AIR LIQUIDE SANTE FRANCE, gaz pour inhalation, pour évaporateur fixe
Tour Hekla
Hypoxemic acute respiratory failure
1 trial -
PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN
Tour Hekla
Recurrent Erysipelas in lower limbs
1 trial -
RIFADINE 300 mg, gélule, ANSATIPINE 150 mg, gélule
Tour Hekla
Adult with an staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy)
1 trial -
SODIUM CHLORIDE , RITUXIMAB, MYCOPHENOLIC ACID
Tour Hekla
Intersitial lung disease related to systemic sclerosis
1 trial
Frequently asked questions
How many pipeline programs does Tour Hekla have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs